Can a tapeworm drug protect high risk kidney patients from Covid-19?
We're helping to fund an urgent clinical trial testing if a drug used for tapeworm can protect high-risk kidney patients from Covid-19. If successful, the trial may pave the way for a new treatment to prevent or alleviate the impact of Covid-19 in people on dialysis, those who have had a kidney transplant, and people with auto-immune diseases affecting the kidneys.
To mark #FreeWillsMonth, use our free Will writing service to get expert support. Or why not set yourself a fundraising challenge in 2021. Alternatively, buy a ticket in our new Weekly Lottery where you could win up to £10,000. However you want to show your support, you can help fund vital kidney research.
Andy Cole has set up the Andy Cole Fund to help people like him, who are living with kidney disease. The money raised goes towards vital research into transplants and finding the best ways to support patients’ mental health and wellbeing.
Support the Andy Cole Fund today and help kick kidney disease to the sideline. Together, we can change the game.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.